Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.

Kadriu B, Gold PW, Luckenbaugh DA, Lener MS, Ballard ED, Niciu MJ, Henter ID, Park LT, De Sousa RT, Yuan P, Machado-Vieira R, Zarate CA.

Mol Psychiatry. 2018 Jul;23(7):1626-1631. doi: 10.1038/mp.2017.109. Epub 2017 May 30.

2.

Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.

Park M, Newman LE, Gold PW, Luckenbaugh DA, Yuan P, Machado-Vieira R, Zarate CA Jr.

J Psychiatr Res. 2017 Jan;84:113-118. doi: 10.1016/j.jpsychires.2016.09.025. Epub 2016 Sep 30.

3.

Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression.

Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA Jr, Machado-Vieira R.

Expert Rev Clin Pharmacol. 2017 Feb;10(2):153-166. doi: 10.1080/17512433.2017.1253472. Epub 2017 Jan 16. Review.

4.

Klotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depression.

Pavlatou MG, Remaley AT, Gold PW.

Transl Psychiatry. 2016 Aug 30;6(8):e876. doi: 10.1038/tp.2016.135. Review.

5.

The role of adipokines in the rapid antidepressant effects of ketamine.

Machado-Vieira R, Gold PW, Luckenbaugh DA, Ballard ED, Richards EM, Henter ID, De Sousa RT, Niciu MJ, Yuan P, Zarate CA Jr.

Mol Psychiatry. 2017 Jan;22(1):127-133. doi: 10.1038/mp.2016.36. Epub 2016 Apr 5.

6.

Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications.

Gold PW, Pavlatou MG, Michelson D, Mouro CM, Kling MA, Wong ML, Licinio J, Goldstein SA.

Transl Psychiatry. 2015 Jun 2;5:e576. doi: 10.1038/tp.2015.38.

7.

Interparental violence and maternal mood disorders as predictors of adolescent physical aggression within the family.

Narayan AJ, Chen M, Martinez PP, Gold PW, Klimes-Dougan B.

Aggress Behav. 2015 May;41(3):253-66. doi: 10.1002/ab.21569.

8.

Clinical and biochemical manifestations of depression: relation to the neurobiology of stress.

Gold PW, Machado-Vieira R, Pavlatou MG.

Neural Plast. 2015;2015:581976. doi: 10.1155/2015/581976. Epub 2015 Mar 24. Review.

9.

The organization of the stress system and its dysregulation in depressive illness.

Gold PW.

Mol Psychiatry. 2015 Feb;20(1):32-47. doi: 10.1038/mp.2014.163. Epub 2014 Dec 9. Review.

PMID:
25486982
10.

Personality disorders in offspring of mothers with mood disorders: results from a longitudinal family study.

Cullen KR, Eberly LE, Heller MD, Schlesinger A, Gold PW, Martinez PE, Klimes-Dougan B.

Psychiatry Res. 2014 Aug 30;218(3):303-10. doi: 10.1016/j.psychres.2014.04.044. Epub 2014 May 9.

11.

Lithium decreases plasma adiponectin levels in bipolar depression.

Soeiro-de-Souza MG, Gold PW, Brunoni AR, de Sousa RT, Zanetti MV, Carvalho AF, Gattaz WF, Machado-Vieira R, Teixeira AL.

Neurosci Lett. 2014 Apr 3;564:111-4. doi: 10.1016/j.neulet.2014.02.005. Epub 2014 Feb 11.

PMID:
24525248
12.

The development of thought problems: a longitudinal family risk study of offspring of bipolar, unipolar, and well parents.

Klimes-Dougan B, Desjardins CD, James MG, Narayan AJ, Long JD, Cullen KR, Gold PW, Martinez PE.

Dev Psychopathol. 2013 Nov;25(4 Pt 1):1079-91. doi: 10.1017/S0954579413000382.

PMID:
24229550
13.

Evidence that stress per se has a role in the precipitation and natural history of depressive illness.

Gold PW.

Mol Psychiatry. 2013 Sep;18(9):954-6. doi: 10.1038/mp.2013.85. No abstract available.

PMID:
23969379
14.

Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.

Pavlatou MG, Vickers KC, Varma S, Malek R, Sampson M, Remaley AT, Gold PW, Skarulis MC, Kino T.

Obesity (Silver Spring). 2013 May;21(5):960-7. doi: 10.1002/oby.20073.

15.

Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depression.

Gold PW, Chrousos GP.

Mol Psychiatry. 2013 Jun;18(6):632-4. doi: 10.1038/mp.2013.5. No abstract available.

PMID:
23698316
16.

Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems.

Gold PW, Licinio J, Pavlatou MG.

Mol Psychiatry. 2013 Feb;18(2):154-65. doi: 10.1038/mp.2012.167. Epub 2012 Nov 27. Review.

PMID:
23183489
17.

In memoriam: Wylie Walker Vale, Jr.

Chrousos GP, Licinio J, Gold PW.

Mol Psychiatry. 2012 Nov;17(11):1052-3. doi: 10.1038/mp.2012.132. No abstract available.

PMID:
23096955
18.

Do premenopausal women with major depression have low bone mineral density? A 36-month prospective study.

Cizza G, Mistry S, Nguyen VT, Eskandari F, Martinez P, Torvik S, Reynolds JC, Gold PW, Sinaii N, Csako G; POWER Study Group.

PLoS One. 2012;7(7):e40894. Epub 2012 Jul 27. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/193f2b29-b8b0-41e8-808a-290df5577a53. Sinai, Ninet [corrected to Sinaii, Ninet].

19.

Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A.

Gold PW, Pavlatou MG, Carlson PJ, Luckenbaugh DA, Costello R, Bonne O, Csako G, Drevets WC, Remaley AT, Charney DS, Neumeister A, Kling MA.

Neurosci Lett. 2012 Jun 27;520(1):1-5. doi: 10.1016/j.neulet.2012.04.072. Epub 2012 May 8.

PMID:
22579817
20.

Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study.

Cizza G, Ronsaville DS, Kleitz H, Eskandari F, Mistry S, Torvik S, Sonbolian N, Reynolds JC, Blackman MR, Gold PW, Martinez PE; P.O.W.E.R. (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group.

PLoS One. 2012;7(1):e28912. doi: 10.1371/journal.pone.0028912. Epub 2012 Jan 3.

21.

Continuity and cascade in offspring of bipolar parents: a longitudinal study of externalizing, internalizing, and thought problems.

Klimes-Dougan B, Long JD, Lee CY, Ronsaville DS, Gold PW, Martinez PE.

Dev Psychopathol. 2010 Nov;22(4):849-66. doi: 10.1017/S0954579410000507.

PMID:
20883586
22.

Low early morning plasma cortisol in posttraumatic stress disorder is associated with co-morbid depression but not with enhanced glucocorticoid feedback inhibition.

Vythilingam M, Gill JM, Luckenbaugh DA, Gold PW, Collin C, Bonne O, Plumb K, Polignano E, West K, Charney D.

Psychoneuroendocrinology. 2010 Apr;35(3):442-50. doi: 10.1016/j.psyneuen.2009.08.006. Epub 2009 Sep 18.

PMID:
19766403
23.

CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.

Barr CS, Dvoskin RL, Yuan Q, Lipsky RH, Gupte M, Hu X, Zhou Z, Schwandt ML, Lindell SG, McKee M, Becker ML, Kling MA, Gold PW, Higley D, Heilig M, Suomi SJ, Goldman D.

Arch Gen Psychiatry. 2008 Aug;65(8):934-44. doi: 10.1001/archpsyc.65.8.934.

24.

Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans?

Elenkov IJ, Kvetnansky R, Hashiramoto A, Bakalov VK, Link AA, Zachman K, Crane M, Jezova D, Rovensky J, Dimitrov MA, Gold PW, Bonini S, Fleisher T, Chrousos GP, Wilder RL.

J Immunol. 2008 Aug 1;181(3):1737-45.

25.

Long-term outcomes of youth who manifested the CBCL-Pediatric Bipolar Disorder phenotype during childhood and/or adolescence.

Meyer SE, Carlson GA, Youngstrom E, Ronsaville DS, Martinez PE, Gold PW, Hakak R, Radke-Yarrow M.

J Affect Disord. 2009 Mar;113(3):227-35. doi: 10.1016/j.jad.2008.05.024. Epub 2008 Jul 15.

PMID:
18632161
26.

Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist.

Horn TL, Harder JB, Johnson WD, Curry PT, Parchment RE, Morrissey RL, Mellick PW, Calis KA, Gold PW, Rice KC, Contoreggi C, Charney DS, Cizza G, Glaze ER, Tomaszewski JE, McCormick DL.

Toxicology. 2008 Jun 3;248(1):8-17. doi: 10.1016/j.tox.2008.03.002. Epub 2008 Mar 13.

27.

Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression.

Krishnamurthy P, Romagni P, Torvik S, Gold PW, Charney DS, Detera-Wadleigh S, Cizza G; P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group.

Horm Metab Res. 2008 Mar;40(3):194-8. doi: 10.1055/s-2007-1004541. Epub 2008 Feb 4.

PMID:
18246526
28.

Homeopathy--quackery or a key to the future of medicine?

Gold PW, Novella S, Roy R, Marcus D, Bell I, Davidovitch N, Saine A.

Homeopathy. 2008 Jan;97(1):28-33. doi: 10.1016/j.homp.2007.12.002.

PMID:
18194763
29.

Low bone mass in premenopausal women with depression.

Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S, Ronsaville D, Wesley R, Toomey C, Sebring NG, Reynolds JC, Blackman MR, Calis KA, Gold PW, Cizza G; Premenopausal, Osteoporosis Women, Alendronate, Depression (POWER) Study Group.

Arch Intern Med. 2007 Nov 26;167(21):2329-36.

PMID:
18039992
30.

3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6-type cytokine actions by targeting the glycoprotein 130 subunit: potential clinical implications.

Kino T, Boos TL, Sulima A, Siegel EM, Gold PW, Rice KC, Chrousos GP.

J Allergy Clin Immunol. 2007 Aug;120(2):437-44. Epub 2007 Apr 23.

PMID:
17451794
31.

Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.

Kling MA, Alesci S, Csako G, Costello R, Luckenbaugh DA, Bonne O, Duncko R, Drevets WC, Manji HK, Charney DS, Gold PW, Neumeister A.

Biol Psychiatry. 2007 Aug 15;62(4):309-13. Epub 2006 Dec 18.

32.

Activation of blood coagulation in patients with major depressive disorder during euglycemic hyperinsulinemia.

Horne MK 3rd, Merryman PK, Cullinane AM, Cai J, Martinez PE, Kling MA, Gold PW.

Thromb Res. 2007;120(4):517-21. Epub 2006 Dec 8. No abstract available.

33.

Potential uses of corticotropin-releasing hormone antagonists.

Zoumakis E, Rice KC, Gold PW, Chrousos GP.

Ann N Y Acad Sci. 2006 Nov;1083:239-51. Review.

PMID:
17148743
34.

Depression and osteoporosis in men: association or casual link?

Ilias I, Alesci S, Gold PW, Chrousos GP.

Hormones (Athens). 2006 Jan-Mar;5(1):9-16. Review.

35.

Intramuscular administration of ACTH1-24 vs. 24-hour blood sampling in the assessment of adrenocortical function.

Alesci S, Ilias I, Souvatzoglou E, Harris AG, Gold PW, Ayala AR, Chrousos GP.

Hormones (Athens). 2005 Apr-Jun;4(2):96-100.

36.

A prospective high-risk study of the association among maternal negativity, apparent frontal lobe dysfunction, and the development of bipolar disorder.

Meyer SE, Carlson GA, Wiggs EA, Ronsaville DS, Martinez PE, Klimes-Dougan B, Gold PW, Radke-Yarrow M.

Dev Psychopathol. 2006 Spring;18(2):573-89.

PMID:
16600068
37.

Development of a human mitochondria-focused cDNA microarray (hMitChip) and validation in skeletal muscle cells: implications for pharmaco- and mitogenomics.

Alesci S, Manoli I, Michopoulos VJ, Brouwers FM, Le H, Gold PW, Blackman MR, Rennert OM, Su YA, Chrousos GP.

Pharmacogenomics J. 2006 Sep-Oct;6(5):333-42. Epub 2006 Mar 14.

PMID:
16534508
38.

Maternal and environmental factors influence the hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone infusion in offspring of mothers with or without mood disorders.

Ronsaville DS, Municchi G, Laney C, Cizza G, Meyer SE, Haim A, Radke-Yarrow M, Chrousos G, Gold PW, Martinez PE.

Dev Psychopathol. 2006 Winter;18(1):173-94.

PMID:
16478558
39.

L-Carnitine and acetyl-L-carnitine in the treatment of complications associated with HIV infection and antiretroviral therapy.

Ilias I, Manoli I, Blackman MR, Gold PW, Alesci S.

Mitochondrion. 2004 Jul;4(2-3):163-8.

PMID:
16120381
40.

Mood disorders in the medically ill: scientific review and recommendations.

Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, O'Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits P Jr, Valvo WJ.

Biol Psychiatry. 2005 Aug 1;58(3):175-89. Review.

PMID:
16084838
41.

Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis.

Johnson EO, Kamilaris TC, Calogero AE, Gold PW, Chrousos GP.

Eur J Endocrinol. 2005 Jul;153(1):177-85.

PMID:
15994759
42.

Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk.

Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, Sebring N, Drinkard BE, Levy C, Reynolds JC, Csako G, Gold PW, Horne M, Cizza G; POWER (Premenopausal, Odteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group.

Metabolism. 2005 Jul;54(7):918-24.

PMID:
15988701
43.

Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia.

Gold PW, Wong ML, Goldstein DS, Gold HK, Ronsaville DS, Esler M, Alesci S, Masood A, Licinio J, Geracioti TD Jr, Perini G, DeBellis MD, Holmes C, Vgontzas AN, Charney DS, Chrousos GP, McCann SM, Kling MA.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8303-8. Epub 2005 May 26.

44.

Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.

Alesci S, De Martino MU, Ilias I, Gold PW, Chrousos GP.

Neuroimmunomodulation. 2005;12(1):1-19. Review.

PMID:
15756049
45.

Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.

Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, Chrousos GP, Gold PW.

J Clin Endocrinol Metab. 2005 May;90(5):2522-30. Epub 2005 Feb 10.

PMID:
15705924
46.

Neurobiological characteristics of rhesus macaque abusive mothers and their relation to social and maternal behavior.

Maestripieri D, Lindell SG, Ayala A, Gold PW, Higley JD.

Neurosci Biobehav Rev. 2005 Feb;29(1):51-7. Epub 2004 Dec 8.

PMID:
15652254
47.

Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm.

Ayala AR, Pushkas J, Higley JD, Ronsaville D, Gold PW, Chrousos GP, Pacak K, Calis KA, Gerald M, Lindell S, Rice KC, Cizza G.

J Clin Endocrinol Metab. 2004 Nov;89(11):5729-37.

PMID:
15531536
48.

A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder.

Meyer SE, Carlson GA, Wiggs EA, Martinez PE, Ronsaville DS, Klimes-Dougan B, Gold PW, Radke-Yarrow M.

Dev Psychopathol. 2004 Spring;16(2):461-76.

PMID:
15487606
49.

Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress.

Charmandari E, Merke DP, Negro PJ, Keil MF, Martinez PE, Haim A, Gold PW, Chrousos GP.

J Clin Endocrinol Metab. 2004 May;89(5):2228-36.

PMID:
15126546
50.

Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: dissociation of concentrations in central and peripheral compartments.

Wong ML, Licinio J, Yildiz BO, Mantzoros CS, Prolo P, Kling M, Gold PW.

J Clin Endocrinol Metab. 2004 Jan;89(1):258-65.

PMID:
14715859

Supplemental Content

Support Center